Exelixis, Inc
Article Abstract:
A comparative analysis of the company sales and financial details of Exelixis, Inc. from 1998 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, Company sales and earnings, Company earnings/profit
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Exelixis, Inc
Article Abstract:
The price appreciation potential of Exelixis, Corp. for the years 2010-2012 is discussed. The San Francisco, California-based company develops drugs through comparative and model system genomics.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Evaluation, Stocks, Stock prices
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Biotechnology industry, Biotechnology industries, Securities, Exelixis Inc., Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.